GP

Gerhard Prante

Director Director DIN 09516360
DIN 09516360 First appointment May 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2022
Shareholding value Locked Premium profile

About Gerhard Prante

Data last updated:

Gerhard Prante has 4 years in corporate governance. Formerly with 1 company, such as Cohizon Life Sciences Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09516360
Primary Designation Director
First Appointment 25 May 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Cohizon Life Sciences Limited U51900MH1983PLC030874
Director25 May 20221983Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cohizon Life Sciences Limited
Premium access

Shareholding and investment profile for Gerhard Prante

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gerhard Prante

Gerhard Prante has 4 years in corporate governance. Formerly with 1 company, such as Cohizon Life Sciences Limited. Engaged in General Business. Contributes to corporate operations.

Gerhard Prante is associated with 0 companies as a director.

Gerhard Prante has expertise in General Business.

Gerhard Prante has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available